Abiopharma

🔍 Weinhoff Gregory M (Executive)

Company: Centessa Pharmaceuticals plc (CNTA)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Sold 61,253 shares of Ordinary Shares at $26.1668 per share (Direct)
  Date: 2026-03-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 77,868.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 11,943 shares of Ordinary Shares at $27.157 per share (Direct)
  Date: 2026-03-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 65,925.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4

Footnotes:

• F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
• F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.75 to $26.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.805 to $27.445, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.